This assumed a direct, causative link between Aβ deposition and the pathophysiologic processes underlying AD, and originated from genetic evidence regarding the overexpression of the Aβ precursor protein (APP) gene in AD patients. This evidence concerns the gene APP and Alzheimer disease.